MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04263nam a2200481 i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
TR-AnTOB |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230926092444.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr cnu|||unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
230518s2023 nju o 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781119819950 |
| Qualifying information |
(electronic bk. : oBook) |
|
|---|
| International Standard Book Number |
1119819954 |
| Qualifying information |
(electronic bk. : oBook) |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1002/9781119819950 |
| Source of number or code |
doi |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)1379304089 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DG1 |
| Language of cataloging |
eng |
| Description conventions |
rda |
| -- |
pn |
| Transcribing agency |
DG1 |
| Modifying agency |
TR-AnTOB |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
İngilizce |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QZ 266 |
| Item number |
P922 |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
|---|
| Classification number |
QZ 266 |
| Item number |
P922 2023 EBK |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Precision cancer therapies. |
| Number of part/section of a work |
Volume 1, |
| Name of part/section of a work |
Targeting oncogenic drivers and signaling pathways in lymphoid malignancies : |
| Remainder of title |
from concept to practice / |
| Statement of responsibility, etc. |
edited by Owen A. O'Connor, Stephen M. Ansell, John F. Seymour |
| 246 30 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Targeting oncogenic drivers and signaling pathways in lymphoid malignancies |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Hoboken, NJ : |
| Name of producer, publisher, distributor, manufacturer |
Wiley Blackwell, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2023 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 340 ## - PHYSICAL MEDIUM |
|---|
| Source |
rdacc |
| Authority record control number or standard number |
http://rdaregistry.info/termList/RDAColourContent/1003 |
| 506 ## - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Available to OhioLINK libraries |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice focuses on lymphoma, an area which has seen a remarkable number of breakthroughs in the ongoing development of precision cancer therapies. Each section on a specific biology or class of drugs has an introductory chapter written by an authority in the field, exclusively focused on the science and its relevance to cancer biology. This approach addresses the need for scientists, physicians, and the private sector to understand the broader context of the extraordinary advances that have produced such astonishing advances in the disease. The work primarily focuses on how to understand and translate fundamental principles of basic science into information that can be directly applied to patients - hence the subtitle, From Concept to Practice. To aid in readers' comprehension, the first page of each chapter contains a box entitled 'Take Home Points'. This short text will highlight the major unique points about the information contained within the chapter. Some of the key topics addressed in the work are as follows: Biological basis of the lymphoid malignancies: fundamental principles of lymphomagenesis and molecular classification of lymphoid malignancies; Targeting programmed cell death: principles for understanding the many types of cell death and promising combinations of drugs targeting apoptosis; Targeting the PI3K pathway: understanding the intricacies of this complex biology and precisely how targeted drugs can be leveraged therapeutically; Targeting the cancer epigenome: pharmacologic features of drugs targeting the epigenome and future prospects for targeting various aspects of epigenetic control; Targeting the tumour proteome: understanding the mechanisms of protein degradation in cancer including both older drugs like proteasome inhibitors, and newer PROTAC based approaches |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Lymphomas |
| Authority record control number or standard number |
https://id.loc.gov/authorities/subjects/sh85079154 |
| General subdivision |
Treatment. |
| Authority record control number or standard number |
https://id.loc.gov/authorities/subjects/sh99005040 |
|
|---|
| Topical term or geographic name entry element |
Cellular signal transduction. |
| Authority record control number or standard number |
https://id.loc.gov/authorities/subjects/sh89002397 |
|
|---|
| Topical term or geographic name entry element |
Lymphoma |
| General subdivision |
therapy. |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D008223Q000628 |
|
|---|
| Topical term or geographic name entry element |
Signal Transduction. |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D015398 |
|
|---|
| Topical term or geographic name entry element |
Molecular Targeted Therapy. |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D058990 |
|
|---|
| Topical term or geographic name entry element |
Tumor Microenvironment. |
| Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D059016 |
| 655 #0 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books |
| 9 (RLIN) |
2032 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
O'Connor, Owen A., |
| Authority record control number or standard number |
https://id.loc.gov/authorities/names/n2020184152 |
| Relator term |
editor |
|
|---|
| Personal name |
Ansell, Stephen M., |
| Authority record control number or standard number |
https://id.loc.gov/authorities/names/no2008027310 |
| Relator term |
editor |
|
|---|
| Personal name |
Seymour, John F., |
| Authority record control number or standard number |
https://id.loc.gov/authorities/names/n89669647 |
| Relator term |
editor |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Ohio Library and Information Network. |
| Authority record control number or standard number |
https://id.loc.gov/authorities/names/no95058981 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Wiley Online Library |
| Public note |
Connect to resource |
| Uniform Resource Identifier |
<a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119819950">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119819950</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
National Library of Medicine |
| Koha item type |
E-Book |
